BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2014
View Archived Issues
Group develops novel small-molecule polymerase inhibitor to contain measle outbreaks
Read More
Researchers develop and test novel oral Shigella challenge model
Read More
BMS presents oral pan-Notch inhibitor for cancer
Read More
First preclinical results for AMA-0428 as treatment for wet AMD
Read More
Lysophospholipid LPA2 receptor ligands for radiation injury synthesized
Read More
ADC Therapeutics patents novel antibody-drug conjugates for cancer
Read More
Connexios Life Sciences and Boehringer Ingelheim form AMPK activator agreement
Read More
Azaya Therapeutics enters collaboration for ATI-1123
Read More
Phase II data trace path towards development of LTX-109
Read More
NanoViricides reports drug candidates for MERS coronavirus infection
Read More
IDH1 gene mutation-specific vaccine developed for treatment of patients with glioma
Read More
NN-8555 demonstrates efficacy and safety in phase II Crohn's disease trial
Read More
FDA accepts MK-3475 BLA for review in advanced melanoma
Read More
Cancer Genetics launches hematological cancer diagnostics
Read More
Shire outlines progress of first quarter 2014
Read More
C-Cure receives EMA certification of quality data
Read More
Japanese researchers disclose novel agents for Alzheimer's disease
Read More
Bristol-Myers Squibb discloses novel coagulation factor XIa inhibitors
Read More
Mologen files clinical trial applications for phase III trial of anticancer immunostimulant
Read More
Roche divulges new TRPA1 antagonists
Read More
Janssen submits sNDA to FDA for Olysio in combination with sofosbuvir
Read More
Novel compounds for HIV infection designed by Laboratoire Biodim
Read More
Favorable safety and efficacy of ITI-007 against acutely exacerbated schizophrenia
Read More
AbbVie files for E.U. approval of HCV regimen
Read More
Pacira files sNDA for nerve block indication for liposomal bupivacaine
Read More
Santhera re-files European MAA for Raxone
Read More